Advancing Precision Oncology (APO) Presents:
Peak Perspectives in Cutaneous Oncology
Aurora, CO
August 7, 2026
Advancing Precision Oncology (APO) Presents:
August 7, 2026
Advancing Innovation in Cutaneous Oncology Through Collaboration and Discovery
Advancing Precision Oncology (APO), an initiative of Advancing Precision Medicine (APM), is proud to present the inaugural Peak Perspectives in Cutaneous Oncology, taking place in Aurora, Colorado, in partnership with the University of Colorado Anschutz Cancer Center.
Chaired by Dr. Sapna Patel, Dr. William Robinson Endowed Chair in Cancer Research and Director of the Cutaneous Oncology and Cell Therapy for Solid Tumors Programs at the University of Colorado Anschutz Cancer Center, this one-day meeting will bring together distinguished national and international experts in melanoma and cutaneous oncology for a focused program highlighting emerging advances, evolving treatment strategies, and multidisciplinary perspectives shaping the future of skin cancer care.
The inaugural conference will also serve as a special celebration honoring the extraordinary career and contributions of Dr. William Robinson, whose longstanding leadership, mentorship, and dedication to melanoma research and patient care have profoundly impacted the field and generations of clinicians and investigators.
Designed to foster collaboration and meaningful discussion among clinicians, researchers, and healthcare professionals, the program will feature expert-led presentations and discussions addressing advances in melanoma therapeutics, immunotherapy, translational research, rare cutaneous malignancies, and precision medicine approaches in oncology.
Peak Perspectives in Cutaneous Oncology aims to provide a unique educational experience while recognizing and celebrating Dr. Robinson’s tremendous contributions to the advancement of melanoma care and research.
Continuing education credits (7.00 CME/CE/CPE and ABPath MOC) are planned for this activity. Complimentary registration, meals, and parking are provided to support broad participation and access to this important educational program.
Agenda
| August 7, 2026 | |
|---|---|
| 7:00 AM | Registration & Check-in |
| 7:55 AM | Welcome & Introductions |
| 8:00 AM | Primary Treatment: Methods and Margins Mariah Brown, MD, Cherry Hills Dermatology; Caleb Freeman, MD, University of Colorado Anschutz School of Medicine; Ryan Lanning, MD, PhD, University of Colorado Anschutz School of Medicine; Martin McCarter, MD, University of Colorado Anschutz School of Medicine; Christoffer Gebhardt, MD, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany; Brian Cervenka, MD, University of Colorado Anschutz School of Medicine; Joshua Wisell, MD, University of Colorado Anschutz School of Medicine |
| 8:40 AM | Adjuvant & Neoadjuvant Therapy Christoffer Gebhardt, MD, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany; Axel Hauschild, MD, University Hospital Schleswig-Holstein, Campus Kiel, Germany; Marlana Orloff, MD, Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University; Isabella Glitza Oliva, MD, PhD, The University of Texas MD Anderson Cancer Center; Martin McCarter, MD, University of Colorado Anschutz School of Medicine; Mark Faries, MD, The Angeles Clinic and Research Institute; Brian Cervenka, MD, University of Colorado Anschutz School of Medicine; Shyam Raghavan, MD, University of Colorado Anschutz School of Medicine |
| 9:20 AM | Breakfast/Exhibits |
| 9:50 AM | Non-CME Session |
| 10:10 AM | Break/Exhibits |
| 10:40 AM | First-Line Treatment of Metastatic Melanoma Maximilian Julve, MBBS, Stanford University School of Medicine; Isabella Glitza Oliva, MD, PhD, The University of Texas MD Anderson Cancer Center; Sapna Patel, MD, University of Colorado Anschutz Cancer Center; Marlana Orloff, MD, Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University; Christoffer Gebhardt, MD, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany; Axel Hauschild, MD, University Hospital Schleswig-Holstein, Campus Kiel, Germany |
| 11:20 AM | Surgery for Metastatic Disease Mark Faries, MD, The Angeles Clinic and Research Institute; Martin McCarter, MD, University of Colorado Anschutz School of Medicine; Brian Cervenka, MD, University of Colorado Anschutz School of Medicine; Carissa Thomas, MD, PhD, FACS, University of Colorado Anschutz School of Medicine; Ryan Lanning, MD, PhD, University of Colorado Anschutz School of Medicine; Isabella Glitza Oliva, MD, PhD, The University of Texas MD Anderson Cancer Center; Marlana Orloff, MD, Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University; Axel Hauschild, MD, University Hospital Schleswig-Holstein, Campus Kiel, Germany |
| 12:00 PM | Translations from the Bench Kasey Couts, PhD, CU Center for Rare Melanomas |
| 12:20 PM | Lunch/Exhibits |
| 12:50 PM | Non-CME Session |
| 1:30 PM | Break/Exhibits |
| 2:00 PM | Cell Therapy as an Emerging Treatment Martin McCarter, MD, University of Colorado Anschutz School of Medicine; Ali Farmer, BSN, RN-BC, UCHealth University of Colorado Hospital; Caleb Freeman, MD, University of Colorado Anschutz School of Medicine; Maximilian Julve, MBBS, Stanford University School of Medicine; Mark Faries, MD, The Angeles Clinic and Research Institute; Isabella Glitza Oliva, MD, PhD, The University of Texas MD Anderson Cancer Center; Marlana Orloff, MD, Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University |
| 2:40 PM | Immunotherapy Toxicity Christina Davis, PharmD, BCOP, University of Colorado Cancer Center; Sapna Patel, MD, University of Colorado Anschutz Cancer Center; Marlana Orloff, MD, Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University; Isabella Glitza Oliva, MD, PhD, The University of Texas MD Anderson Cancer Center; Axel Hauschild, MD, University Hospital Schleswig-Holstein, Campus Kiel, Germany; Christoffer Gebhardt, MD, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany; Mark Faries, MD, The Angeles Clinic and Research Institute |
| 3:20 PM | CNS Metastases in Melanoma Isabella Glitza Oliva, MD, PhD, The University of Texas MD Anderson Cancer Center; Ryan Lanning, MD, PhD, University of Colorado Anschutz School of Medicine; Marlana Orloff, MD, Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University; Christoffer Gebhardt, MD, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany; Maximilian Julve, MBBS, Stanford University School of Medicine |
| 4:00 PM | Break |
| 4:10 PM | Non-Melanoma Skin Cancer Axel Hauschild, MD, University Hospital Schleswig-Holstein, Campus Kiel, Germany; Christoffer Gebhardt, MD, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany; Carissa Thomas, MD, PhD, FACS, University of Colorado Anschutz School of Medicine; Joshua Wisell, MD, University of Colorado Anschutz School of Medicine; Shyam Raghavan, MD,University of Colorado Anschutz School of Medicine |
| 4:50 PM | Uveal Melanoma Marlana Orloff, MD, Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University; Martin McCarter, MD, University of Colorado Anschutz School of Medicine; Sapna Patel, MD, University of Colorado Anschutz Cancer Center; Christoffer Gebhardt, MD, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany; Ryan Lanning, MD, PhD, University of Colorado Anschutz School of Medicine; |
| 5:30 PM | A Celebration of Dr. William Robinson’s Legacy |
Speakers
THE LOCATION
Gaylord Rockies Resort & Convention Center
6700 North Gaylord Rockies Boulevard
Aurora, Colorado 80019






























